Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil ®9 in Young Women
Conditions: Cervical Cancer; Condylomata Acuminata Interventions: Biological: Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli); Biological: Gardasil ®9 Sponsors: Xiamen Ophthalmology Center Affiliated to Xiamen University; Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials

Anti-cancer Neoantigen Polypeptide Vaccine to Treat Solid Tumors
Conditions: Solid Tumor, Adult Interventions: Biological: Neoantigen Polypeptide Vaccine Sponsors: Second Affiliated Hospital of Guangzhou Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials

Anti-cancer Neoantigen mRNA Vaccine to Treat Solid Tumors
Conditions: Solid Tumor, Adult Interventions: Biological: Neoantigen mRNA Vaccine Sponsors: Second Affiliated Hospital of Guangzhou Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials

Personalized Vaccine for TNBC Immunotherapy
Conditions: Breast Cancer Female Interventions: Biological: Peptide pulsed autologous Dendritic cell Sponsors: Universidad Nacional de Colombia; Fundaci ón Salud de los Andes Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials

Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer
Conditions: Non-muscle Invasive Bladder Cancer; HER-2 Protein Overexpression Interventions: Drug: Disitamab vedotin; Drug: Bacillus Calmette Guerin Vaccine Sponsors: Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 1, 2024 Category: Research Source Type: clinical trials

Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation
Conditions: Pneumococcal Vaccine; Esophageal Cancer; Lymphopenia; Chemoradiation Interventions: Biological: Pneumonia vaccine Sponsors: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials

Autologous TLPO Vaccine Basket
Conditions: Tumor, Solid; Tumor Metastasis; Cancer; Tumor Interventions: Biological: Tumor lysate, particle only (TLPO) vaccine Sponsors: Elios Therapeutics, LLC; LumaBridge Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials

COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research
Conditions: COVID-19 Recurrent; Lung Cancer; Vaccination; Antibody; Chemotherapy; Immune Checkpoint Inhibitor Interventions: Biological: Any Chinese government-recommended COVID-19 booster vaccine Sponsors: Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials

HPV Vaccine Reminders - SEARCH II Study
Conditions: Human Papillomavirus Vaccination Interventions: Behavioral: Text Message/automated phone reminder Sponsors: Columbia University; Makerere University; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials

Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
SAN JOSE, Calif., Dec. 6, 20203. Anixa Biosciences ( " Anixa " or the " Company " ), a biotechnology company focused on the treatment and prevention of cancer, today announced new and updated positive results from the Phase 1 clinical trial of its... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 7, 2023 Category: Pharmaceuticals Source Type: clinical trials

Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino
Conditions: Pancreatic Cancer Interventions: Drug: Adebrelimab; Drug: mRNA tumor vaccines Sponsors: Fudan University; Shanghai Regenelead Therapies Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials

Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
Conditions: Metastatic Colorectal Cancer Interventions: Drug: Retifanlimab; Biological: Therapeutic CEA, Brachyury and MUC1 TriAdeno Vaccine Platform; Drug: N-803; Drug: SX-682 Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials

Antibiotics and Vaccine Immune Responses Study
Conditions: Vaccine Response Impaired Interventions: Biological: BCG vaccine; Biological: Yellow Fever vaccine; Drug: Vancomycin Oral Capsule; Drug: Neomycin Oral Product Sponsors: South Australian Health and Medical Research Institute; Royal Adelaide Hospital; Flinders University; University of Sydney; Telethon Kids Institute; Centenary Institute of Cancer Medicine and Cell Biology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials

Real-world Effectiveness of HPV Vaccine in Women Living With HIV and Its Impact on Cervical Cancer Screening Accuracies
Conditions: Hiv; Hpv Interventions: Diagnostic Test: HPV test using Evalyn Brush Sponsors: University of California, Los Angeles; Harvard School of Public Health (HSPH); Frontier Science& Technology Research Foundation, Inc.; Albert Einstein College of Medicine; Boston Children ' s Hospital; St. Jude Children ' s Research Hospital; University of Colorado, Denver; Bronx-Lebanon Hospital Center Health Care System; University of Miami; Baylor College of Medicine; Children ' s Hospital New Orleans, LA; Jacobi Medical Center; Ann& Robert H Lurie Children ' s Hospital of Chicago; Westat Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials

Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer
Conditions: Pancreas Cancer Interventions: Biological: Biological/Vaccine: Blood sample and tissue sample Sponsors: Institut du Cancer de Montpellier - Val d ' Aurelle Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials